Giulia Bon Selected Research

Integrin alpha6beta4

7/2009	Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
2/2008	Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas.
2/2007	The alpha6beta4 integrin can regulate ErbB-3 expression: implications for alpha6beta4 signaling and function.
1/2007	Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progression.
6/2006	Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giulia Bon Research Topics

Disease

8	Neoplasms (Cancer) 04/2022 - 06/2006
7	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2005
4	Carcinoma (Carcinomatosis) 01/2014 - 01/2007
1	Melanoma (Melanoma, Malignant) 04/2022
1	Liposarcoma 11/2018
1	Myxoid Liposarcoma 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Colonic Neoplasms (Colon Cancer) 12/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2017

Drug/Important Bio-Agent (IBA)

5	Integrin alpha6beta4IBA 07/2009 - 06/2006
4	IntegrinsIBA 01/2014 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 06/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2022 - 12/2017
2	Pharmaceutical PreparationsIBA 11/2018 - 02/2008
2	Laminin ReceptorsIBA 01/2014 - 06/2006
2	Integrin beta4IBA 07/2009 - 06/2006
2	Hormones (Hormone)IBA 02/2008 - 06/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2007 - 06/2006
1	Indicators and Reagents (Reagents)IBA 04/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 12/2020
1	pertuzumabIBA 12/2020
1	TrabectedinIBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	VimentinIBA 11/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017
1	Polycomb-Group ProteinsIBA 09/2014
1	STAT5 Transcription FactorIBA 01/2014
1	DisintegrinsIBA 01/2014
1	ADAM17 ProteinIBA 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 07/2009
1	Tamoxifen FDA LinkGeneric 02/2008
1	ErbB-3 ReceptorIBA 02/2008
1	Small Interfering RNA (siRNA)IBA 06/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2006
1	CollagenIBA 12/2005
1	rho-Associated KinasesIBA 12/2005
1	Cytoskeletal ProteinsIBA 12/2005
1	TropomyosinIBA 12/2005

Therapy/Procedure

6	Therapeutics 04/2022 - 06/2006
1	Immunotherapy 01/2022
1	Adjuvant Chemotherapy 11/2018